47
NPS Score
VS
Alkermes Claimed Company
- EMPLOYEE
PARTICIPANTS - 37
- TOTAL
RATINGS
Karyopharm Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 90
- TOTAL
RATINGS
Alkermes vs Karyopharm Therapeutics
Compare Alkermes versus Karyopharm Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 37 employees and customers of Alkermes and 90 employees and customers of Karyopharm Therapeutics.
Alkermes
Alkermes's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Alkermes. Their current market cap is $3.05B.
Karyopharm Therapeutics
Karyopharm Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Karyopharm Therapeutics. Their current market cap is $753.30M.
4/5
Product Quality
5/5
4/5
Pricing
5/5
4.2/5
Customer Service
5/5
| 60% | Promoters |
|---|---|
| 27% | Passive |
| 13% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 53
See how Alkermes compares to its competitors
See how Karyopharm Therapeutics compares to its competitors
Working at Alkermes vs Working at Karyopharm Therapeutics
73 / 100
CEO Rating
82 / 100
CEO Rating
Winner by 9%
Alkermes
Alkermes doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Karyopharm Therapeutics
Employees at Karyopharm Therapeutics rate their CEO, Richard Paulson, 82/100. This score is 9% higher than the scores of Alkermes' CEO, Richard Pops. Employees in the IT and Sales departments rate Richard Paulson the highest.